AGER and synovial sarcoma: In SS patients with high disease activity, HMGB1, as well as soluble RAGE (sRAGE) levels, are elevated, suggesting that HMGB1 and its counterpart sRAGE are involved in the etiology of SS, and that the HMGB1/RAGE axis could be a therapeutic target [22] (Figure 1).